As per the report published by the U.S. National Health Statistics Report, GAS pharyngitis is one of the primary causes that has led to an increase in the number of patients being admitted to the emergency ward in the country. Moreover, group A beta-hemolytic streptococcus is one of the leading causes of streptococcal pharyngitis among adults and children. The diagnosis of strep throat is imperative and increasingly gaining momentum, owing to a surge in the number of deaths due to chronic rheumatic heart disease. GAS pharyngitis diagnostics has, thus, received a great amount of attention over the past few years and gained considerable traction across diagnostic laboratories, hospitals, and physician clinics worldwide.
Companies in the GAS pharyngitis diagnostics market are affected by a range of challenges. At present, one of the biggest challenges within the GAS pharyngitis diagnostics market is providing accurate, efficient, and accessible diagnostics. However, with significant groundwork, an influx of new training programs, growing support from government organizations, and promising outcome from R&D activities, GAS pharyngitis diagnostics is likely to gain significant momentum during the forecast period. Due to these factors, the global GAS pharyngitis diagnostics market is expected to attain a market value of ~US$ 204 Mn by the end of 2027.
GAS pharyngitis diagnostics continues to remain a major challenge due to which, opting for the right treatment remains a constant roadblock. In the current scenario, antibiotics are primarily used to treat pharyngitis from bacterial infection. However, due to the significant rise in antimicrobial resistance, the adoption of antibiotics is declining-a factor that is expected to encourage research activities and finding an accurate diagnosis.
Culture tests are predominantly regarded as the gold standard in the GAS pharyngitis diagnostics market. However, the downside of these culture-based tests includes the large time gap between sample collection and attaining results. Over the past decade, due to a significant amount of research and advancements in the medical field, an array of rapid tests have emerged within the GAS pharyngitis diagnostics market that is predominantly based on immunoassays and in recent times, on molecular assays. While immunoassays, including immunochromatographic assays, optical immunoassays, and enzyme immunoassays are deployed, molecular assays that are based on techniques such as polymerase chain reaction, DNA probes, and fluorescence in situ hybridization are also gaining considerable traction across the world.
Primary factors that are expected to accelerate the demand for rapid tests in the upcoming years include faster diagnostics and prevention of inappropriate use of antibiotics. At present, research and development activities are largely aimed at increasing the accuracy of rapid tests and make them more cost-effective. Despite the growing adoption of rapid tests, culture tests for antimicrobial susceptibility testing will continue to stay in demand. Rapid test kit is set to dominate the GAS pharyngitis diagnostics market in terms of market share and value.
For companies operating within the current GAS pharyngitis diagnostics market, improving accuracy and speed of the overall diagnostic procedure is expected to be a major area of interest. Several companies are currently in the process of attaining approval from the U.S. Food and Drug Administration (FDA). Some of the major players involved in the market, including Quidel Corporation and Abbott, are increasingly allocating funds for the development of new assays and a host of healthcare products. For instance, in October 2018, Abbott revealed that the U.S. FDA approved the company’s Influenza A & B 2 and Strep A 2 molecular assays. In addition, with the development of new assays, GAS pharyngitis diagnostics results can be achieved at a faster rate. In addition, the recently developed assays can be deployed in both patient as well as inpatient settings, such as physician offices, emergency rooms, walk-in clinics, etc. With additional research, new and cost-effective GAS pharyngitis diagnostics solutions that are currently in the research phase are projected to enter the market.
Analysts’ Viewpoint
The global GAS pharyngitis diagnostics market is expected to grow at a CAGR of 2.5% during the forecast period. Some of the key factors that will most likely influence the growth of the market include a consistent growth in the number of GAS pharyngitis patients, high focus on research and development, and promising results offered by rapid test kits and continual support from government bodies worldwide. While culture tests will continue to remain an integral part of the entire GAS pharyngitis diagnostics market, the demand for rapid test kits will remain higher during the forecast period. Companies should continue investing in research and development activities and focus on obtaining approval from the FDA for their new assays.
GAS pharyngitis diagnostics Market – Segmentation
TMR’s study on the global GAS pharyngitis diagnostics market includes information divided into three sections ? product, end user, and region. Changing industry trends and other crucial market dynamics associated with these sections of the global GAS pharyngitis diagnostics market have been discussed in detail.
|
Product |
Rapid Test Kit Culture Test PCR-based Test |
|
End User |
Physician Clinics Diagnostic Laboratories Hospitals |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
GAS pharyngitis diagnostics market is expected to attain a market value of ~US$ 204 Mn by the end of 2027
GAS pharyngitis diagnostics market to expand at a CAGR of 2.5% from 2019 to 2027
GAS pharyngitis diagnostics market is driven by increase in incidence and prevalence of GAS pharyngitis infection across the globe
North America accounted for a major share of the global GAS pharyngitis diagnostics market during the forecast period
Key players in the GAS pharyngitis diagnostics market include Quidel Corporation, BD, Abbott Laboratories, bioMérieux SA, Hoffmann-La Roche Ltd, Beckman Coulter, Inc. (Danaher)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global GAS Pharyngitis Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Strategies of Top 3 Players Operating in the Market
5.2. Key Industrial Events
6. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by Product, 2017-2027
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2027
6.3.1. Rapid Test Kit
6.3.2. Culture Test
6.3.3. PCR-based Test
6.4. Global GAS Pharyngitis Diagnostics Market Attractiveness, by Product
7. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by End-user, 2017-2027
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017–2027
7.3.1. Physician Office
7.3.2. Diagnostic Laboratories
7.3.3. Hospitals
7.4. Global GAS Pharyngitis Diagnostics Market Attractiveness, by End-user
8. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by Region, 2017-2027
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global GAS Pharyngitis Diagnostics Market Attractiveness, by Region
9. North America GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027
9.1. Introduction
9.1.1. Key Findings
9.2. North America GAS Pharyngitis Diagnostics Market Value Forecast, by Product, 2017–2027
9.2.1. Rapid Test Kit
9.2.2. Culture Test
9.2.3. PCR-based Test
9.3. North America GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-2027
9.3.1. Physician Office
9.3.2. Diagnostic Laboratories
9.3.3. Hospitals
9.4. North America GAS Pharyngitis Diagnostics Market Value Forecast, by Country, 2017-2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America GAS Pharyngitis Diagnostics Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027
10.1. Introduction
10.1.1. Key Finding
10.2. Europe GAS Pharyngitis Diagnostics Market Value Forecast, by Product, 2017-2027
10.2.1. Rapid Test Kit
10.2.2. Culture Test
10.2.3. PCR-based Test
10.3. Europe GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-2027
10.3.1. Physician Office
10.3.2. Diagnostic Laboratories
10.3.3. Hospitals
10.4. Europe GAS Pharyngitis Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Europe GAS Pharyngitis Diagnostics Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027
11.1. Introduction
11.1.1. Key Finding
11.2. Asia Pacific GAS Pharyngitis Diagnostics Market Value Forecast, by Product, 2017-2027
11.2.1. Rapid Test Kit
11.2.2. Culture Test
11.2.3. PCR-based Test
11.3. Asia Pacific GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-2027
11.3.1. Physician Office
11.3.2. Diagnostic Laboratories
11.3.3. Hospitals
11.4. Asia Pacific GAS Pharyngitis Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific GAS Pharyngitis Diagnostics Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027
12.1. Introduction
12.1.1. Key Finding
12.2. Latin America GAS Pharyngitis Diagnostics Market Value Forecast, by Product, 2017-2027
12.2.1. Rapid Test Kit
12.2.2. Culture Test
12.2.3. PCR-based Test
12.3. Latin America GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-2027
12.3.1. Physician Office
12.3.2. Diagnostic Laboratories
12.3.3. Hospitals
12.4. Latin America GAS Pharyngitis Diagnostics Market Value Forecast by Country/Sub-region, 2017-2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America GAS Pharyngitis Diagnostics Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027
13.1. Introduction
13.1.1. Key Finding
13.2. Middle East & Africa GAS Pharyngitis Diagnostics Market Value Forecast, by Product, 2017-2027
13.2.1. Rapid Test Kit
13.2.2. Culture Test
13.2.3. PCR-based Test
13.3. Middle East & Africa GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-2027
13.3.1. Physician Office
13.3.2. Diagnostic Laboratories
13.3.3. Hospitals
13.4. Middle East & Africa GAS Pharyngitis Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa GAS Pharyngitis Diagnostics Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Comparative Ranking Analysis by Company (2018)
14.3. Company Profiles
14.3.1. Quidel Corporation
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Company Financials
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. BD
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Company Financials
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Abbott Laboratories
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Company Financials
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. bioMérieux SA
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Company Financials
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. F. Hoffmann-La Roche Ltd
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Company Financials
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Beckman Coulter, Inc. (Danaher)
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Company Financials
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Meridian Bioscience, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Company Financials
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. DiaSorin S.p.A.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Company Financials
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. Sekisui Diagnostics
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Company Financials
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis
List of Tables
Table 01: Global GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 03: Global GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 04: North America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 05: North America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 06: North America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 07: Europe GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 08: Europe GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 09: Europe GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 10: Asia Pacific GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 11: Asia Pacific GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 12: Asia Pacific GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 13: Latin America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 14: Latin America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 15: Latin America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 16: Middle East & Africa GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 17: Middle East & Africa GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 18: Middle East & Africa GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figures
Figure 01: Global GAS Pharyngitis Diagnostics market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Key Industrial Development in the GAS Pharyngitis Diagnostic Companies (1/2)
Figure 03: Key Industrial Development in the GAS Pharyngitis Diagnostic Companies (2/2)
Figure 04: Global GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, 2017–2027
Figure 05: Global GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018
Figure 06: Global GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018
Figure 07: Global GAS Pharyngitis Diagnostics Market Value Share, by Region, 2018
Figure 08: Global GAS Pharyngitis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
Figure 09: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Rapid Test Kit, 2017–2027
Figure 10: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Culture Test, 2017–2027
Figure 11: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PCR-based Test, 2017-2027
Figure 12: Global GAS Pharyngitis Diagnostics Market Attractiveness Analysis, by Product, 2019–2027
Figure 13: Global GAS Pharyngitis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 14: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician Clinics, 2017–2027
Figure 15: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017–2027
Figure 16: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2027
Figure 17: Global GAS Pharyngitis Diagnostics Market Attractiveness Analysis, by End-user, 2019–2027
Figure 18: Global GAS Pharyngitis Diagnostics Market Value Share, by Region, 2018 and 2027
Figure 19: Global GAS Pharyngitis Diagnostics Market Attractiveness Analysis, by Region, 2019–2027
Figure 20: North America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 21: North America GAS Pharyngitis Diagnostics Market Value Share, by Country, 2018 and 2027
Figure 22: North America GAS Pharyngitis Diagnostics Market Attractiveness, by Country, 2019–2027
Figure 23: North America GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018 and 2027
Figure 24: North America GAS Pharyngitis Diagnostics Market Attractiveness, by Product, 2019–2027
Figure 25: North America GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018 and 2027
Figure 26: North America GAS Pharyngitis Diagnostics Market Attractiveness, by End-user, 2019–2027
Figure 27: Europe GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 28: Europe GAS Pharyngitis Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 29: Europe GAS Pharyngitis Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 30: Europe GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018 and 2027
Figure 31: Europe GAS Pharyngitis Diagnostics Market Attractiveness, by Product, 2019–2027
Figure 32: Europe GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018 and 2027
Figure 33: Europe GAS Pharyngitis Diagnostics Market Attractiveness, by End-user, 2019–2027
Figure 34: Asia Pacific GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 35: Asia Pacific GAS Pharyngitis Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 36: Asia Pacific GAS Pharyngitis Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 37: Asia Pacific GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018 and 2027
Figure 38: Asia Pacific GAS Pharyngitis Diagnostics Market Attractiveness, by Product, 2019–2027
Figure 39: Asia Pacific GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018 and 2027
Figure 40: Asia Pacific GAS Pharyngitis Diagnostics Market Attractiveness, by End-user, 2019–2027
Figure 41: Latin America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 42: Latin America GAS Pharyngitis Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 43: Latin America GAS Pharyngitis Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 44: Latin America GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018 and 2027
Figure 45: Latin America GAS Pharyngitis Diagnostics Market Attractiveness, by Product, 2019–2027
Figure 46: Latin America GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018 and 2027
Figure 47: Latin America GAS Pharyngitis Diagnostics Market Attractiveness, by End-user, 2019–2027
Figure 48: Middle East & Africa GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 49: Middle East & Africa GAS Pharyngitis Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 50: Middle East & Africa GAS Pharyngitis Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 51: Middle East & Africa GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018 and 2027
Figure 52: Middle East & Africa GAS Pharyngitis Diagnostics Market Attractiveness, by Product, 2019–2027
Figure 53: Middle East & Africa GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018 and 2027
Figure 54: Middle East & Africa GAS Pharyngitis Diagnostics Market Attractiveness, by End-user, 2019–2027
Figure 55: Quidel Corporation Breakdown of Net Sales, by Region, 2018 (%)
Figure 56: Quidel Corporation Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2018
Figure 57: Becton, Dickinson. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 58: Becton, Dickinson. Breakdown of Net Sales (%), by Region/Country, 2018
Figure 59: Becton, Dickinson. Revenue Breakdown of Net Sales (%), by Business Segment, 2018
Figure 60: Becton, Dickinson. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 61: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 62: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 63: Breakdown of Net Sales (% Share), by Business Segment, 2018
Figure 64: Breakdown of Net Sales (% Share), by Region, 2018
Figure 65: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 66: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 67: Breakdown of Net Sales (% Share), by Application, 2018
Figure 68: Breakdown of Net Sales (% Share), by Region, 2018
Figure 69: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 70: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 71: Breakdown of Net Sales (% Share), by Business Segment, 2018
Figure 72: Breakdown of Net Sales (% Share), by Region, 2018
Figure 73: Danaher Diagnostics Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 74: R&D Intensity (US$ Mn), Diagnostics Business Segment, 2015–2017
Figure 75: Breakdown of Net Sales (%), Danaher Diagnostics Business Segment, by Region, 2018
Figure 76: Breakdown of Net Sales (%), Danaher Diagnostics Business Segment, by Product, 2018
Figure 77: Meridian Bioscience Inc. Breakdown of Net Sales, by Region, 2018 (%)
Figure 78: Meridian Bioscience Inc. Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2018
Figure 79: DiaSorin S.p.A. Revenue (US$ Mn), 2015–2018
Figure 80: DiaSorin S.p.A. R&D Expenses (US$ Mn), 2015–2018
Figure 81: DiaSorin S.p.A. Breakdown of Net Sales (%), by Region, 2018
Figure 82: DiaSorin S.p.A. Sales and Marketing Expenses (US$ Mn, 2015–2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
GAS Pharyngitis Diagnostics Market
